WaferGen Files for Sale of 112M Shares by Stockholders | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems has filed for the potential sale of more than 112 million shares of its common stock by its stockholders.

In a Form S-1 filed with the US Securities and Exchange Commission on Tuesday, WaferGen said it will not receive proceeds from the offering, but will receive $34.8 million if warrants included in the offering are exercised in full. Those funds would be used for working capital and general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.